NCT06535399 2026-01-23Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic ImpairmentCelgenePhase 1 Completed29 enrolled
NCT06352528 2025-10-06A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic ImpairmentBristol-Myers SquibbPhase 1 Completed18 enrolled